Met Life Investment Management, LLC Innoviva, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 34,961 shares of INVA stock, worth $631,745. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,961
Previous 33,230 5.21%
Holding current value
$631,745
Previous $641,000 5.46%
% of portfolio
0.0%
Previous 0.0%

Shares

41 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$17.35 - $20.32 $30,032 - $35,173
1,731 Added 5.21%
34,961 $606,000
Q2 2024

Aug 13, 2024
BUY
$14.4 - $16.4 $2,260 - $2,574
157 Added 0.47%
33,230 $544,000
Q1 2024

May 14, 2024
BUY
$14.56 - $16.78 $481,542 - $554,964
33,073 New
33,073 $504,000
Q2 2023

Apr 29, 2024
BUY
$11.39 - $13.72 $376,701 - $453,761
33,073 New
33,073 $421,000
Q1 2023

May 09, 2024
BUY
$10.73 - $13.6 $354,873 - $449,792
33,073 New
33,073 $372 Million
Q2 2022

May 10, 2024
BUY
$14.32 - $19.88 $122,436 - $169,974
8,550 Added 34.87%
33,073 $488,000
Q2 2022

Mar 22, 2023
BUY
$14.32 - $19.88 $122,436 - $169,974
8,550 Added 34.87%
33,073 $488,000
Q2 2022

Aug 11, 2022
BUY
$14.32 - $19.88 $122,436 - $169,974
8,550 Added 34.87%
33,073 $488,000
Q1 2022

May 10, 2024
BUY
$15.39 - $20.25 $377,408 - $496,590
24,523 New
24,523 $474,000
Q1 2022

Jun 20, 2023
SELL
$15.39 - $20.25 $131,584 - $173,137
-8,550 Reduced 25.85%
24,523 $474,000
Q1 2022

Mar 22, 2023
BUY
$15.39 - $20.25 $137,017 - $180,285
8,903 Added 57.0%
24,523 $474,000
Q1 2022

May 12, 2022
BUY
$15.39 - $20.25 $137,017 - $180,285
8,903 Added 57.0%
24,523 $475,000
Q4 2021

Jun 21, 2023
SELL
$15.91 - $18.72 $277,677 - $326,720
-17,453 Reduced 52.77%
15,620 $269,000
Q3 2021

May 17, 2024
SELL
$13.06 - $17.24 $130,573 - $172,365
-9,998 Reduced 39.03%
15,620 $261,000
Q3 2021

Jun 21, 2023
SELL
$13.06 - $17.24 $227,936 - $300,889
-17,453 Reduced 52.77%
15,620 $261,000
Q3 2021

Mar 22, 2023
SELL
$13.06 - $17.24 $130,573 - $172,365
-9,998 Reduced 39.03%
15,620 $261,000
Q3 2021

Nov 15, 2021
SELL
$13.06 - $17.24 $130,573 - $172,365
-9,998 Reduced 39.03%
15,620 $261,000
Q2 2021

Jun 21, 2023
SELL
$11.45 - $13.96 $85,359 - $104,071
-7,455 Reduced 22.54%
25,618 $343,000
Q1 2021

May 17, 2024
SELL
$11.06 - $12.87 $82,452 - $95,945
-7,455 Reduced 22.54%
25,618 $306,000
Q1 2021

Jun 26, 2023
SELL
$11.06 - $12.87 $82,452 - $95,945
-7,455 Reduced 22.54%
25,618 $306 Million
Q1 2021

Mar 22, 2023
BUY
$11.06 - $12.87 $16,811 - $19,562
1,520 Added 6.31%
25,618 $306,000
Q1 2021

May 14, 2021
BUY
$11.06 - $12.87 $16,811 - $19,562
1,520 Added 6.31%
25,618 $306,000
Q4 2020

May 24, 2024
SELL
$9.33 - $12.48 $86,171 - $115,265
-9,236 Reduced 27.71%
24,098 $298,000
Q4 2020

Jun 22, 2023
SELL
$9.33 - $12.48 $83,736 - $112,008
-8,975 Reduced 27.14%
24,098 $298,000
Q4 2020

Mar 22, 2023
SELL
$9.33 - $12.48 $86,171 - $115,265
-9,236 Reduced 27.71%
24,098 $298,000
Q4 2020

Feb 16, 2021
SELL
$9.33 - $12.48 $86,171 - $115,265
-9,236 Reduced 27.71%
24,098 $299,000
Q3 2020

Jun 26, 2023
BUY
$10.33 - $14.49 $2,696 - $3,781
261 Added 0.79%
33,334 $348,000
Q2 2020

May 24, 2024
BUY
$11.49 - $15.26 $2,998 - $3,982
261 Added 0.79%
33,334 $466 Million
Q2 2020

Jun 26, 2023
BUY
$11.49 - $15.26 $2,998 - $3,982
261 Added 0.79%
33,334 $466,000
Q1 2020

Jul 12, 2023
BUY
$8.11 - $15.23 $2,116 - $3,975
261 Added 0.79%
33,334 $392,000
Q4 2019

Jul 12, 2023
BUY
$10.28 - $14.38 $2,683 - $3,753
261 Added 0.79%
33,334 $472,000
Q3 2019

Jul 12, 2023
BUY
$10.05 - $14.55 $2,623 - $3,797
261 Added 0.79%
33,334 $351,000
Q2 2019

Jul 12, 2023
BUY
$13.1 - $14.95 $3,419 - $3,901
261 Added 0.79%
33,334 $485,000
Q1 2019

Jul 13, 2023
BUY
$13.69 - $20.06 $3,573 - $5,235
261 Added 0.79%
33,334 $467,000
Q4 2018

Jul 13, 2023
BUY
$13.96 - $18.26 $3,643 - $4,765
261 Added 0.79%
33,334 $581,000
Q4 2018

Mar 22, 2023
SELL
$13.96 - $18.26 $235,337 - $307,827
-16,858 Reduced 33.59%
33,334 $581,000
Q4 2018

Feb 14, 2019
SELL
$13.96 - $18.26 $235,337 - $307,827
-16,858 Reduced 33.59%
33,334 $582,000
Q3 2018

Jul 13, 2023
BUY
$13.63 - $15.7 $3,557 - $4,097
261 Added 0.79%
33,334 $508,000
Q3 2018

Mar 22, 2023
BUY
$13.63 - $15.7 $233,331 - $268,768
17,119 Added 51.76%
50,192 $764,000
Q3 2018

Nov 14, 2018
BUY
$13.63 - $15.7 $229,774 - $264,670
16,858 Added 50.57%
50,192 $765,000
Q4 2017

Feb 15, 2018
BUY
$11.73 - $14.75 $391,007 - $491,676
33,334
33,334 $473,000

Others Institutions Holding INVA

# of Institutions
243
Shares Held
77.7M
Call Options Held
52.8K
Put Options Held
800
View Full List

About Innoviva, Inc.

INVA Quotes by TradingView
  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.26B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email